Evidence map›Paper›PMID 41438979›Full record

SynthesisFrontiers in oncology2025

Association between

Xiaohui Bai, Li Gao, Jiawei Zhao, Wentao Liao, Yujing Chen, Xiaotong Guo, Jiamin Jin, Bo Ge

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaohui Bai *Department of Urology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Li Gao *Department of Urology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Jiawei Zhao *Department of Urology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Wentao LiaoDepartment of Urology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.
Yujing ChenKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, China.
Xiaotong GuoKey Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, China.
Jiamin Jin *Key Laboratory of Tumor Immunology and Microenvironmental Regulation, Guilin Medical University, Guilin, Guangxi, China.
Bo Ge *Department of Urology, The Second Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gene polymorphisms of Objective: To investigate the association between Materials and methods: PubMed, Medline, and CNKI were searched. Associations were assessed using odds ratios (ORs) with 95% confidence intervals (CIs). The false-positive report probability (FPRP), Bayesian false discovery probability (BFDP), and Venetian criteria were used to evaluate the credibility of statistically significant findings. Results: We found for the first time that, overall, the Conclusions: Overall, the results suggest a potential association between the

Indexed as

BFDPESRFPRPmeta-analysispolymorphismprostate cancer

Identifiers

PMID41438979
PMCPMC12719423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.